Sanofi has in principle reached a settlement related to its discontinued heartburn drug Zantac, though the French pharma did not disclose the financial terms of the deal.
Tag Archive for: ranitidine
An International Chamber of Commerce arbitration tribunal has dismissed a claim by Boehringer Ingelheim against Sanofi in a dispute over legal responsibilities related to ranitidine-based product Zantac, the French multinational company announced Tuesday.
Lawyers for a man who alleges he developed bladder cancer after taking GSK Plc’s heartburn drug Zantac urged a California judge on Thursday to allow expert testimony linking the drug to the illness at an upcoming trial.
The FDA issued complete response letters to Phathom Pharmaceuticals, flagging the presence of N-nitroso-vonoprazan (NVP) impurities detected in the company’s approved Helicobacter pylori drug products, the company announced Thursday.
Shares of GSK and Sanofi surged on Wednesday, adding more than $20 billion in combined value in early trade following the dismissal of thousands of U.S. lawsuits claiming that the heartburn drug Zantac caused cancer.
